Michael Aberman

Interim Chief Business Officer at Excision BioTherapeutics - Philadelphia, PA, US

Michael Aberman's Contact Details
HQ
N/A
Location
New York, New York, United States
Company
Excision BioTherapeutics
Michael Aberman's Company Details
Excision BioTherapeutics logo, Excision BioTherapeutics contact details

Excision BioTherapeutics

Philadelphia, PA, US • 20 - 49 Employees
BioTech/Drugs

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

Biotechnology
Details about Excision BioTherapeutics
Frequently Asked Questions about Michael Aberman
Michael Aberman currently works for Excision BioTherapeutics.
Michael Aberman's role at Excision BioTherapeutics is Interim Chief Business Officer.
Michael Aberman's email address is ***@excision.bio. To view Michael Aberman's full email address, please signup to ConnectPlex.
Michael Aberman works in the BioTech/Drugs industry.
Michael Aberman's colleagues at Excision BioTherapeutics are Taylor Rae Hudson, Marvin Au, Sumathi MD, Franz Gerner, Robert Gunning, Lucas Buchheim-Jurisson and others.
Michael Aberman's phone number is N/A
See more information about Michael Aberman